High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome.
We report a 14-month-old male with infantile opsoclonus polymyoclonia syndrome. His clinical disabilities responded favorably to high-dose human immunoglobulin therapy. High dose immunoglobulin therapy is one of the therapies for patients with this syndrome.
Sugie
H
H
Department of Pediatrics, Hamamatsu University School of Medicine, Japan.
Sugie
Y
Y
Akimoto
H
H
Endo
K
K
Shirai
M
M
Ito
M
M
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D009207:Myoclonus / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D009460:Neurologic Examination; D015835:Ocular Motility Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011597:Psychomotor Performance / Q000187:drug effects; D013577:Syndrome
D016756:Immunoglobulins, Intravenous; D011239:Prednisolone